Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes

计划入组 20 人 · 首次发布于 2016 年 11 月 17 日

A Study to Evaluate the Effect of Latanoprostene Bunod Ophthalmic Solution 0.024% on Episcleral Venous Pressure and Outflow Facility in Participants With Ocular Hypertension

首次发布于 2019 年 10 月 25 日

Safety and Tolerability Study of QLS-101 in Adolescents With Sturge-Weber Syndrome (SWS)-Related Glaucoma Due to Elevated Episcleral Venous Pressure (EVP)

计划入组 2 人 · 首次发布于 2022 年 8 月 10 日

High blood pressure(FunPep)

Phosphatidyl serine(EnBrace HR, EnLyte)

C₄₂H₈₂NO₁₀P

Sulodexide

Rx

Inari Medical

United States

NANO Nuclear Energy

Bloom Energy

Qlaris Bio Appoints Fred Guerard as CEO as QLS-111 Glaucoma Drug Enters Phase 3 Development

Qlaris Bio Develops Novel Fixed-Dose Combination Therapy Targeting Unaddressed Component of Glaucoma Treatment

Qlaris Bio Initiates Phase II Trial for Novel Glaucoma Therapy QLS-111 in South Korea